FDA Drug Shortages — Page 34
Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,660 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Naltrexone Hydrochloride Tablet | Resolved — Elite Laboratories, Inc. |
| Dextrose Monohydrate 5% Injection | Current — Otsuka ICU Medical LLC |
| Methylphenidate Hydrochloride Tablet, Extended Release | Current — Teva Pharmaceuticals USA, Inc. |
| Technetium TC-99M Pyrophosphate Kit Injection | Current — Curium US LLC |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Current — Hospira, Inc., a Pfizer Company |
| Dexmedetomidine Hydrochloride Injection | Current — Pfizer Inc. |
| Adalimumab-adaz Injection | To Be Discontinued — Sandoz Inc. |
| Rifampin Capsule | Current — Lupin Pharmaceuticals, Inc. |
| Pemetrexed Disodium Injection | To Be Discontinued — Eli Lilly and Co. |
| Dexmedetomidine Hydrochloride Injection | Current — Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
← Previous
Page 34 of 34